You have 9 free searches left this month | for more free features.

GST, DILI, biomarker

Showing 1 - 25 of 3,511

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug-induced Liver Injury Trial in Beijing

Recruiting
  • Drug-induced Liver Injury
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 27, 2022

    Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

    Recruiting
    • Drug-Induced Liver Injury
    • +2 more
    • MT2004 Capsule
    • MT2004 Capsule Placebo
    • Shanghai, Shanghai, China
      Shanghai Jiaotong University School of Medicine,Renji Hospital
    Aug 25, 2023

    Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

    Recruiting
    • Tuberculosis
    • +2 more
    • N acetyl cysteine
    • Bangkok, Thailand
      Faculty of Medicine, Siriraj Hospital
    Feb 12, 2023

    Anorexia Nervosa, Atypical Anorexia Nervosa (Other Specified Eating Disorder), Bulimia Nervosa Trial (GST, CBT-E)

    Not yet recruiting
    • Anorexia Nervosa
    • +3 more
    • GST
    • CBT-E
    • (no location specified)
    Apr 13, 2023

    Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

    Completed
    • Healthy Participant
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 11, 2023

    COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)

    Recruiting
    • COVID-19 Pneumonia
    • GST-HG171 Tablets
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 26, 2023

    COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)

    Completed
    • COVID-19 Pneumonia
    • GST-HG171 Tablets
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 26, 2023

    COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)

    Active, not recruiting
    • COVID-19 Respiratory Infection
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 10, 2023

    COVID-19 Trial in Changchun (GST-HG171, of GST-HG171)

    Recruiting
    • COVID-19
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Dec 25, 2022

    COVID-19 Pneumonia Trial (GST-HG171/Ritonavir, Placebo)

    Not yet recruiting
    • COVID-19 Pneumonia
    • (no location specified)
    Dec 18, 2022

    Chronic Hepatitis b Trial in Changchun (GST-HG141)

    Recruiting
    • Chronic Hepatitis b
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Dec 5, 2022

    Healthy Volunteers Trial in Fujian (GST-HG151, Placebo)

    Recruiting
    • Healthy Volunteers
    • Fujian, Fuzhou, China
      Mengchao Hepatpbiliary Hospital of Fujian Medical University
    Apr 19, 2022

    Hepatitis B Trial in Changchun (GST-HG141 tablets, Matching Placebos for GST-HG141 tablets)

    Completed
    • Hepatitis B
    • GST-HG141 tablets
    • Matching Placebos for GST-HG141 tablets
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Jun 6, 2022

    Cluster C Personality Disorder (Diagnosis), Mother-Child Relations Trial (Group schematherapy)

    Not yet recruiting
    • Cluster C Personality Disorder (Diagnosis)
    • Mother-Child Relations
    • Group schematherapy
    • (no location specified)
    Oct 21, 2023

    Stroke, Acute Trial in France (Blood Samples)

    Recruiting
    • Stroke, Acute
    • Blood Samples
    • Bar-le-Duc, France
    • +4 more
    Jun 27, 2022

    Fatty Liver Trial in Naples

    Completed
    • Fatty Liver
      • Naples, Italy
        University of Campania Luigi Vanvitelli
      Mar 27, 2023

      Pharmacokinetics, Food Affect, Single Ascending Dose Trial in Changchun (GST-HG121 tablets, Placebo)

      Recruiting
      • Pharmacokinetics
      • +3 more
      • GST-HG121 tablets
      • Placebo
      • Changchun, Jilin, China
        The first hospital of Jilin University
      Dec 26, 2022

      Susceptibility Genes for APAP Induced Drug Induced LIver Injury

      Recruiting
      • Acetaminophen
      • +3 more
      • genetic polymorphism
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Jul 14, 2021

      Drug-induced Liver Injury, Gut Microbiota, Biochemical Markers Trial in Wuhan (Collect stool and blood samples from patients)

      Recruiting
      • Drug-induced Liver Injury
      • +2 more
      • Collect stool and blood samples from patients
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Jul 20, 2022

      Drug-induced Liver Injury,Chronic Trial in Beijing (36 Weeks Methylprednisolone, 48 weeks Methylprednisolone)

      Active, not recruiting
      • Drug-induced Liver Injury,Chronic
      • 36 Weeks Methylprednisolone
      • 48 weeks Methylprednisolone
      • Beijing, China
        Beijing 302 hospital
      Sep 3, 2021

      PreDiabetes Trial in Singapore (Single dose of 75 grams glucose in 200ml water)

      Not yet recruiting
      • PreDiabetes
      • Single dose of 75 grams glucose in 200ml water
      • Singapore, Singapore
        Human Development Research Centre, SICS, A*STAR
      Nov 6, 2023

      Blood Based Biomarkers in Primary Care Setting for Alzheimer's

      Enrolling by invitation
      • Mild Cognitive Impairment
      • PrecivityAD
      • Indianapolis, Indiana
        Indiana University Health Physicians Primary Care
      Apr 25, 2023

      MiRNA in Detecting Active Germ Cell Tumors in Early Suspected

      Recruiting
      • Malignant Testicular Germ Cell Tumor
      • Non-Interventional Study
      • Los Angeles, California
      • +1 more
      Sep 28, 2023

      Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)

      Active, not recruiting
      • Post Concussive Symptoms
      • Early intervention programme
      • Enhanced usual care
      • (no location specified)
      Apr 11, 2023

      Meningioma Trial in Heidelberg (Explorative biomarker study)

      Not yet recruiting
      • Meningioma
      • Explorative biomarker study
      • Heidelberg, Germany
        University Hospital of Heidelberg, Radiation Oncology
      Oct 23, 2023